|
To use:
1. Enter a word or phrase in the box(es) below.
2. Choose "and" ,"or" or "not" for
multiple words.
3.Click 
When you are ready.
|
| Show results
at a time. |
|
Your search for: "vorinostat"
Displaying 1 through 3 of 3 matches found in abstracts
|
Your search has been listed in order of relevancy
Select All | UnSelect All
 Click the checkbox next to each item to bookmark. | | 1. | [404] Phase I-II study of the histone deacetylase inhibitor (HDACi) vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer (MBC): New York Cancer Consortium trial P7703.  | | | | Authors: Ramaswamy B, Bhalla K, Cohen B, Pellegrino C, Hershman D, Chuang E, Somlo G, Goetz M, Swaby R, Hopkins U, Christos P, Espinoza-Delgado I, Sparano JA | | | | Date/Time: Friday, December 12, 2008 - 7:00 AM | | | | Session Info: Poster Discussion Session: Novel Targeted Therapies (7:00 AM-9:00 AM) | | | | 2. | [2153] Transcriptional gene expression profiles indicate response of breast cancer cell lines to aminoflavone prodrug. | | | | Authors: Shelton PM, Nguyen B, Chen A, Burger AM | | | | Date/Time: Friday, December 12, 2008 - 7:00 AM | | | | Session Info: Poster Session II: Treatment: New Drugs and Treatment Strategies (7:00 AM-9:00 AM) | | | | 3. | [401] A novel combination therapy with histone deacetylase inhibitor and Aurora kinase inhibitor for  triple negative breast cancers. | | | | Authors: Samuel T, Fiskus W, Buser C, Bhalla K | | | | Date/Time: Friday, December 12, 2008 - 7:00 AM | | | | Session Info: Poster Discussion Session: Novel Targeted Therapies (7:00 AM-9:00 AM) | | |
|
